Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
Public ClinicalTrials.gov record NCT00102687. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Open-Label Study Comparing Three Alternative Dosing Regimens of Subcutaneous Azacitidine Plus Best Supportive Care for the Treatment of Myelodysplastic Syndromes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if azacitidine, combined with Best Supportive Care (BSC), is effective in treating myelodysplastic syndromes (MDS) when given according to a different doses and dosing schedules.
Study identification
- NCT ID
- NCT00102687
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Jul 31, 2008
- Completion
- Jul 31, 2008
- Last update posted
- Nov 21, 2019
2005 – 2008
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comprehensive Blood and Cancer Center, Research Department | Bakersfield | California | 93309 | — |
| Tower Cancer Research Foundation | Beverly Hills | California | 90211 | — |
| Cancer Center of Colorado Springs, The Oncology Clinic, PC | Colorado Springs | Colorado | 80907 | — |
| Rocky Mountain Cancer Centers, LLP | Denver | Colorado | 80218 | — |
| Washington Cancer Institute | Washington D.C. | District of Columbia | 20010 | — |
| Florida Cancer Institute | New Port Richey | Florida | 34652 | — |
| Cancer Centers of Florida, P.A. | Ocoee | Florida | 34761 | — |
| Joliet Oncology-Hematology Associates, Ltd. | Joliet | Illinois | 60435 | — |
| Oncology/Hematology Associates of Central Illinois, PC | Peoria | Illinois | 61615-7828 | — |
| Central Indiana Cancer Centers | Indianapolis | Indiana | 46227 | — |
| Hematology & Oncology Specialists LLC | Metairie | Louisiana | 70115 | — |
| Great Lakes Cancer Institute Breslin Cancer Center | Lansing | Michigan | 48910 | — |
| The Center for Cancer Care and Research | St Louis | Missouri | 63141 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Greater Dayton Cancer Center | Kettering | Ohio | 45409 | — |
| Western Pennsylvania Cancer Institute | Pittsburgh | Pennsylvania | 15224 | — |
| Oncology Services of Aberdeen | Aberdeen | South Dakota | 57401 | — |
| Avera Cancer Institute Leukemia-Bone Marrow Transplant Center | Sioux Falls | South Dakota | 57105 | — |
| McLeod Cancer and Blood Center | Johnson City | Tennessee | 37604 | — |
| The Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Texas Oncology, P.A. | Bedford | Texas | 76022 | — |
| Texas Cancer Center at Medical City | Dallas | Texas | 75230 | — |
| Texas Oncology, PA | Fort Worth | Texas | 76104 | — |
| San Antonio Tumor & Blood Clinic | Fredericksburg | Texas | 78624 | — |
| Cancer Care Centers of South Texas - HOAST | San Antonio | Texas | 78229 | — |
| Virginia Oncology Associates - Lake Wright Cancer Center | Norfolk | Virginia | 23502 | — |
| Highline Medical Oncology | Burien | Washington | 98166 | — |
| Puget Sound Cancer Center | Edmonds | Washington | 98026 | — |
| Puget Sound Cancer Center | Seattle | Washington | 98133 | — |
| Cancer Care Northwest | Spokane | Washington | 99218 | — |
| Northwest Cancer Specialists, P.C. | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00102687, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 21, 2019 · Synced Sep 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00102687 live on ClinicalTrials.gov.